OraSure Technologies (NASDAQ: OSUR) and Landauer (NYSE:LDR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, valuation, analyst recommendations, dividends and institutional ownership.

Insider and Institutional Ownership

92.1% of OraSure Technologies shares are held by institutional investors. Comparatively, 79.5% of Landauer shares are held by institutional investors. 6.4% of OraSure Technologies shares are held by company insiders. Comparatively, 6.6% of Landauer shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares OraSure Technologies and Landauer’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OraSure Technologies 22.29% 15.64% 13.88%
Landauer 12.09% 80.03% 10.11%

Analyst Ratings

This is a summary of current recommendations for OraSure Technologies and Landauer, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OraSure Technologies 0 1 5 0 2.83
Landauer 0 1 0 0 2.00

OraSure Technologies presently has a consensus target price of $15.21, suggesting a potential downside of 30.78%. Given OraSure Technologies’ stronger consensus rating and higher possible upside, analysts plainly believe OraSure Technologies is more favorable than Landauer.

Risk & Volatility

OraSure Technologies has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500. Comparatively, Landauer has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500.

Dividends

Landauer pays an annual dividend of $1.10 per share and has a dividend yield of 1.6%. OraSure Technologies does not pay a dividend. Landauer pays out 57.0% of its earnings in the form of a dividend.

Valuation and Earnings

This table compares OraSure Technologies and Landauer’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
OraSure Technologies $135.07 million 9.67 $23.92 million $0.54 40.69
Landauer $153.35 million 4.35 $39.95 million $1.93 35.23

Landauer has higher revenue and earnings than OraSure Technologies. Landauer is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

Summary

OraSure Technologies beats Landauer on 10 of the 16 factors compared between the two stocks.

OraSure Technologies Company Profile

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. It sells over-the-counter (OTC) cryosurgical products to consumers in North America, Europe, Central and South America, and Australia.

Landauer Company Profile

Landauer, Inc. is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products. The Company provides radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries. Medical physics services are provided through the Company’s Landauer Medical Physics (LMP) division. The Company uses LMP as a platform to expand into the medical physics services market, serving domestic hospitals, radiation therapy centers and imaging centers. The Company’s Medical Products segment provides medical consumable accessories used in radiology, radiation therapy and image guided surgery procedures.

Receive News & Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.